CANCER IMMUNOTHERAPY INDEX

The Loncar Cancer Immunotherapy Index seeks to track the combined performance of a basket of companies that develop therapies to treat cancer by harnessing the body's own immune system. Immunotherapy is a transformational field within the biotechnology space that is expected to become a foundational treatment for cancer over the next ten years.  The index will provide a metric to follow its progress as researchers advance new technologies for the benefit of courageous patients who fight the disease.  It is an equal-weighted index containing both large pharmaceutical and growth-oriented biotechnology companies that are leading in this approach.

CNCR pie chart_2019-11-19.jpg
CNCR_Top_5_2019-11-19.jpg

Latest Quote

Index Constituents

Click on a name to learn more about its immunotherapy program

Prices delayed up to 15 min

Moderna_Therapeutics_company_logo.png
regeneron-regn-logo.png
logo-49.png
seagen_logo_3in_4cp_600dpi-2.jpg
21-12-Ymabs-logo-2016.jpg
image2-2.jpg
Autolus_logo.jpg
nK5tFcEmcf6cDDCIBTvthAV6GmY1542707059547
rHqnvszj_400x400.png
precision_revised_logo_1_color-2.png
200px-Zymeworks_Logo.svg.png

Loncar Investments, LLC : P.O Box 15072, Lenexa, KS  66285 : 913-871-5007 : Not investment advice or a solicitation to buy or sell securities